A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...
Apixaban significantly reduces stroke risk in people with subclinical atrial fibrillation and prior stroke history.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback